Anavex Life Sciences Corp (AVXL)

[Talon38]

Doc, I bow to your medical expertise and experience however, the sum total of treatment progress with Alzheimer's is abysmal. The disease is a death sentence and takes a tremendous toll on family and caregivers yet, we continue to spend huge monetary and scientific capital on failure prone research. To make a crude analogy we are trying to save survivors of a ship wreck in the North Atlantic by throwing them life preservers.... we keep throwing preservers to those in the water and they continue to die of exposure. I believe that the current FDA "adaptive/precision" drug development is aimed at "Triage" i.e. save those closest to the life boat by pulling them aboard. We can't save them all but if we do save the XYZ patients we have made progress and the research goes on into early detection, genomic specificity, and combination solutions. Seamless adaptive trials with RWE and continual data feedback seems heresy in light of the large scale, and time consuming trial methodology heretofore. However, Scott Gottlieb and Janet Woodcock appear to be moving the neurodegenerative drug development toward their Cancer Center of Excellence model.